Aspirin treatment exacerbates oral infections by Trypanosoma cruzi
- 1 May 2016
- journal article
- Published by Elsevier in Experimental Parasitology
- Vol. 164, 64-70
Abstract
No abstract availableKeywords
Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (40002012026M9)
- CNPq (306497/2012)
This publication has 41 references indexed in Scilit:
- Trypanosoma cruzi Infection through the Oral Route Promotes a Severe Infection in Mice: New Disease Form from an Old Infection?PLOS Neglected Tropical Diseases, 2015
- Chagas disease in the 21st Century: a public health success or an emerging threat?Parasite, 2014
- Trypanosoma cruzi Entrance through Systemic or Mucosal Infection Sites Differentially Modulates Regional Immune Response Following Acute Infection in MiceFrontiers in Immunology, 2013
- Chagas disease: a new worldwide challengeNature, 2010
- Further comments on oral transmission of Chagas' disease in Brazil: Epidemiology, geographical distribution and viability of the infective parasiteInternational Journal of Cardiology, 2010
- Trypanosoma cruzi: The role of PGE2 in immune response during the acute phase of experimental infectionExperimental Parasitology, 2008
- Trypanosoma cruzi surface molecule gp90 downregulates invasion of gastric mucosal epithelium in orally infected miceMicrobes and Infection, 2006
- Molecular basis of non-virulence of Trypanosoma cruzi clone CL-14International Journal for Parasitology, 2004
- Circulating levels of cyclooxygenase metabolites in experimental Trypanosoma cruzi infectionsMediators of Inflammation, 2004
- PGE2 involvement in experimental infection with Trypanosoma cruzi subpopulationsProstaglandins, 1995